What You Can Learn From Oxford Nanopore Technologies plc's (LON:ONT) P/SAfter Its 25% Share Price Crash
Apr 26
U.K. (FTSE) Life Sciences Industry Analysis
UpdatedApr 27, 2024
DataAggregated Company Financials
Companies10
- 7D2.4%
- 3M-26.1%
- 1Y-45.3%
- YTD-39.8%
Over the last 7 days, the Life Sciences industry has dropped 1.1%, driven by a pullback from MaxCyte of 5.8%. However, the industry is down 47% over the past year. Looking forward, earnings are forecast to grow by 11% annually.
Industry Valuation and Performance
Has the U.K. Life Sciences Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 27 Apr 2024 | UK£1.5b | UK£317.6m | -UK£178,454,345.45 | 11.9x | -8.3x | 4.7x |
| Mon, 25 Mar 2024 | UK£1.8b | UK£296.0m | -UK£213,289,739.77 | 7353.2x | -8.6x | 6.2x |
| Wed, 21 Feb 2024 | UK£1.9b | UK£285.9m | -UK£189,315,420.21 | 6962.3x | -10.1x | 6.7x |
| Fri, 19 Jan 2024 | UK£2.9b | UK£450.2m | -UK£176,598,755.00 | 60.7x | -16.3x | 6.4x |
| Sun, 17 Dec 2023 | UK£3.1b | UK£450.1m | -UK£174,093,562.00 | 54.8x | -17.7x | 6.8x |
| Tue, 14 Nov 2023 | UK£3.0b | UK£456.3m | -UK£169,339,120.00 | 47.7x | -17.7x | 6.6x |
| Thu, 12 Oct 2023 | UK£3.0b | UK£458.3m | -UK£165,334,304.00 | 53.2x | -18x | 6.5x |
| Sat, 09 Sep 2023 | UK£3.1b | UK£440.4m | -UK£166,946,001.00 | 69.6x | -18.6x | 7x |
| Mon, 07 Aug 2023 | UK£3.4b | UK£476.5m | -UK£124,704,061.00 | 70.6x | -27.1x | 7.1x |
| Wed, 05 Jul 2023 | UK£2.9b | UK£476.6m | -UK£124,755,108.00 | 66.1x | -23.6x | 6.2x |
| Fri, 02 Jun 2023 | UK£3.3b | UK£476.8m | -UK£116,837,105.00 | 67.8x | -28.5x | 7x |
| Sun, 30 Apr 2023 | UK£3.1b | UK£479.9m | -UK£117,165,188.00 | 36.3x | -26.8x | 6.5x |
| Tue, 28 Mar 2023 | UK£2.8b | UK£459.2m | -UK£119,244,847.00 | 34.6x | -23.5x | 6.1x |
| Thu, 23 Feb 2023 | UK£3.1b | UK£443.6m | -UK£183,089,453.00 | 44.1x | -17.2x | 7.1x |
| Sat, 21 Jan 2023 | UK£3.4b | UK£442.7m | -UK£182,486,738.00 | 47.5x | -18.6x | 7.7x |
| Mon, 19 Dec 2022 | UK£3.3b | UK£443.4m | -UK£182,850,729.00 | 48.9x | -18x | 7.4x |
| Wed, 16 Nov 2022 | UK£3.8b | UK£447.6m | -UK£178,735,027.00 | 49.7x | -21.4x | 8.6x |
| Fri, 14 Oct 2022 | UK£9.7b | UK£448.9m | -UK£176,413,127.00 | 42.4x | -54.9x | 21.6x |
| Sun, 11 Sep 2022 | UK£3.8b | UK£366.0m | -UK£191,147,579.00 | 47.3x | -20x | 10.5x |
| Tue, 09 Aug 2022 | UK£3.9b | UK£366.5m | -UK£188,044,029.00 | 47.2x | -21x | 10.8x |
| Thu, 07 Jul 2022 | UK£3.8b | UK£367.1m | -UK£188,275,863.00 | 41.3x | -20x | 10.3x |
| Sat, 04 Jun 2022 | UK£3.8b | UK£360.3m | -UK£192,190,085.00 | 43x | -19.9x | 10.6x |
| Mon, 02 May 2022 | UK£5.2b | UK£922.7m | -UK£165,738,471.00 | 45.1x | -31.3x | 5.6x |
| Wed, 30 Mar 2022 | UK£6.7b | UK£913.5m | -UK£308,686,415.00 | 49.1x | -21.8x | 7.4x |
| Fri, 25 Feb 2022 | UK£7.0b | UK£891.3m | -UK£199,679,897.00 | 43.5x | -35.3x | 7.9x |
| Sun, 23 Jan 2022 | UK£8.0b | UK£849.0m | -UK£184,521,973.00 | 30.4x | -43.4x | 9.4x |
| Tue, 21 Dec 2021 | UK£9.5b | UK£849.8m | -UK£188,455,311.00 | 30.7x | -50.2x | 11.1x |
| Thu, 18 Nov 2021 | UK£9.0b | UK£843.7m | -UK£189,302,594.00 | 22.8x | -47.4x | 10.6x |
| Sat, 16 Oct 2021 | UK£7.6b | UK£819.7m | -UK£188,428,759.00 | 30.9x | -40.6x | 9.3x |
| Mon, 13 Sep 2021 | UK£3.1b | UK£674.8m | -UK£136,626,800.35 | 28.5x | -22.9x | 4.6x |
| Wed, 11 Aug 2021 | UK£2.9b | UK£670.4m | -UK£160,499,800.35 | 63x | -18.2x | 4.3x |
| Sun, 06 Jun 2021 | UK£3.6b | UK£670.8m | -UK£88,500,847.08 | 74.8x | -40.4x | 5.3x |
Price to Earnings Ratio
-42.8x
Current Industry PE
- Investors are pessimistic on the British Life Sciences industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 8.5x is higher than the industry's current PS ratio of 4.6x.
Past Earnings Growth
- The earnings for companies in the Life Sciences industry have deteriorated over the last three years.
- Revenues have also declined 22% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Trends
Which industries have driven the changes within the U.K. Healthcare industry?
| GB Market | 2.84% | |
| Healthcare | 7.01% | |
| Life Sciences | 2.35% | |
| Clinical Research and Equipment | 2.35% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ONT Oxford Nanopore Technologies | UK£0.97 | 4.5% +UK£35.7m | -57.8% | PS4.9x | |
| ERGO Ergomed | UK£13.46 | 0.1% +UK£14.7m | 3.5% | PE46.7x | |
| HVO hVIVO | UK£0.28 | 5.8% +UK£10.5m | 75.7% | PE11.9x | |
| C4XD C4X Discovery Holdings | UK£0.12 | 45.9% +UK£9.5m | -16.4% | PE2.9x | |
| PRM Proteome Sciences | UK£0.042 | 25.8% +UK£2.5m | 1.5% | PS2.4x |